NVST vs PROF · P/E 56, rev $2.51B vs rev $10.7M
Envista Holdings Corp (NVST) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
NVST currently screens at market cap $3.72B and trailing P/E 55.8. PROF currently screens at market cap $238.7M.
Not investment advice. Open the NVST and PROF stock pages for the full models.
Not investment advice.